Cephea Early Feasibility Study
NCT: NCT05061004 · RECRUITING
광고
NCT IDNCT05061004
상태RECRUITING
시작일2022-04-28
완료2031-03-01
SponsorAbbott Medical Devices (INDUSTRY)
First posted
Last updated
간략 요약
The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is deemed more appropriate than open heart surgery.
공식 출처
ClinicalTrials.gov에서 보기 →데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.